Artificial Intelligence is no longer a future concept—it’s already influencing how life sciences organizations approach quality management. In this conversation, Quality Assurance Manager Yijia Lee joins Product Marketing Director Lori Bleau to explore how AI is being applied in quality today, what regulators are saying, and how QA teams can prepare for responsible adoption.

The session will highlight real-world use cases where AI is driving measurable improvements in quality operations, offering practical examples attendees can apply within their own organizations. Participants will also gain insight into the FDA’s evolving perspective on AI, including recent guidance and emerging initiatives such as the Emerging Technology Program (ELSA), helping clarify regulatory expectations and considerations.

Finally, the discussion will focus on readiness—how QA teams can build the skills, processes, and governance needed to adopt AI in a compliant, value-driven way. Whether you are exploring AI for the first time, actively piloting solutions, or aligning your quality strategy with FDA expectations, this session will deliver actionable insights to help you move forward with confidence.

Click here to register.
Certificate of attendance worth 0.1 CEU available.